Skip to main content

Refresh RELIEVA PF

NDC 0023-9537 · Allergan, Inc.

Generic nameCarboxymethylcellulose sodium and Glycerin
Dosage formSOLUTION/ DROPS
RouteOPHTHALMIC
Active ingredient(s)CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN
Strength5; 10 mg/mL; mg/mL
Pharmacologic classAllergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]
Marketing categoryOTC MONOGRAPH DRUG

Packages

0023-9537-05 — 5 VIAL, SINGLE-USE in 1 CARTON (0023-9537-05) / .4 mL in 1 VIAL, SINGLE-USE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0023-4491 — carboxymethylcellulose sodium, glycerin, polysorbate 80, 0023-4515 — Carboxymethylcellulose sodium and Glycerin, 0023-4554 — carboxymethylcellulose sodium, 0023-5459 — carboxymethylcellulose sodium and glycerin, 0023-5773 — Carboxymethylcellulose sodium, Glycerin and Polysorbate 80, 0023-6630 — Carboxymethylcellulose sodium, Glycerin, 0023-6634 — Carboxymethylcellulose sodium and Glycerin, 0023-6952 — Carboxymethylcellulose sodium, Glycerin, Polysorbate 80, 0023-6954 — Carboxymethylcellulose sodium, Glycerin and Polysorbate 80, 0023-7151 — Carboxymethylcellulose sodium, Glycerin and Polysorbate 80, 0065-0426 — Dextran 70, Glycerin, Hypromellose, 0113-0944 — glycerin, phenylephrine HCl, pramoxine HCl, white petrolatum, 0132-0075 — Glycerin, 0132-0185 — glycerin, 0132-0190 — Glycerin, 0132-0195 — Glycerin, 0135-0400 — glycerin, lidocaine, 0363-0445 — Glycerin Suppository, 0363-0449 — Glycerin Suppository, 0363-0499 — Glycerin suspension, +317 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels